Literature DB >> 17174143

Survival of second and multiple primary tumors in patients with oral cavity squamous cell carcinoma in the betel quid chewing area.

Chun-Ta Liao1, Chung-Jan Kang, Joseph Tung-Chieh Chang, Hung-Ming Wang, Shu-Hang Ng, Chuen Hsueh, Li-Yu Lee, Chih Hung Lin, Ann-Joy Cheng, I-How Chen, Shiang-Fu Huang, Tzu-Chen Yen.   

Abstract

We report the incidence, risk factor(s), and overall survival (OS) of second/multiple primary tumors (SPTs/MPTs) in oral cavity squamous cell carcinoma (OSCC) patients in betel quid chewing areas. Of 816 untreated OSCC patients who had radical surgery, 15.7% had either synchronous or metachronous SPTs. The SPTs (70.3%) were at the oral cavity. SPTs (18.8%) developed third primary tumors, with a significantly higher incidence in synchromous than metachronous SPTs (p=0.001). An optimal, but significantly lower, 5-year OS was observed in patients with SPTs/MPTs than without (54.0% vs. 67.2%, p=0.0195). By multivariate analyses, OSCC sub-sites (p=0.006) and lymphatic permeation (p=0.040) were independent risk factors for SPT rate. A significantly higher 5-year OS was observed in SPT patients receiving a second radical surgery at the oral cavity/soft palate than patients that did not (p=0.0001). A good survival rate can be obtained for OSCC patients with resectable SPTs/MPTs.

Entities:  

Mesh:

Year:  2006        PMID: 17174143     DOI: 10.1016/j.oraloncology.2006.10.003

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  23 in total

Review 1.  Open questions and novel concepts in oral cancer surgery.

Authors:  Giancarlo Tirelli; Serena Zacchigna; Matteo Biasotto; Marco Piovesana
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-24       Impact factor: 2.503

Review 2.  Cancer of the oral cavity.

Authors:  Pablo H Montero; Snehal G Patel
Journal:  Surg Oncol Clin N Am       Date:  2015-04-15       Impact factor: 3.495

Review 3.  How Each Component of Betel Quid Is Involved in Oral Carcinogenesis: Mutual Interactions and Synergistic Effects with Other Carcinogens-a Review Article.

Authors:  Shajedul Islam; Malsantha Muthumala; Hirofumi Matsuoka; Osamu Uehara; Yasuhiro Kuramitsu; Itsuo Chiba; Yoshihiro Abiko
Journal:  Curr Oncol Rep       Date:  2019-04-26       Impact factor: 5.075

4.  What should we expect from robotic surgery for second primary oropharyngeal cancer?

Authors:  Tuan-Jen Fang; Li-Ang Lee; Bing-Shan Huang; Chien-Yu Lin; Cheng-Lung Hsu; Joseph Tung-Chieh Chang; Tzu-Chen Yen; Chun-Ta Liao; Hui-Chen Chiang
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-05-09       Impact factor: 2.503

5.  Synchronous malignancies in patients with squamous cell carcinomas of the oral cavity.

Authors:  Feng-Yuan Liu; Chun-Ta Liao; Tzu-Chen Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02-26       Impact factor: 9.236

6.  Prognostic impact of second primary tumors in head and neck cancer.

Authors:  Marta S Patrucco; Marina V Aramendi
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-29       Impact factor: 2.503

7.  Clinical features of multiple primary carcinomas of the oral cavity.

Authors:  Ya-Dong Li; Xin Ma; Yao-Lun Han; Li-Wei Peng
Journal:  Exp Ther Med       Date:  2016-12-27       Impact factor: 2.447

8.  Clinical Features of Oral Multiple Primary Carcinomas Compared with Oral Single Primary Carcinoma.

Authors:  Makoto Kawasaki; Takayuki Tamura; Yusei Harada; Nobuyuki Fujii; Rieko Doi; Isamu Kodani
Journal:  Yonago Acta Med       Date:  2020-09-14       Impact factor: 1.641

9.  Proteomic analysis of anti-tumor effects of 11-dehydrosinulariolide on CAL-27 cells.

Authors:  Chih-I Liu; Cheng-Chi Chen; Jiing-Chuan Chen; Jui-Hsin Su; Han Hsiang Huang; Jeff Yi-Fu Chen; Yu-Jen Wu
Journal:  Mar Drugs       Date:  2011-07-14       Impact factor: 6.085

10.  Polygenic Panels Predicting the Susceptibility of Multiple Upper Aerodigestive Tract Cancer in Oral Cancer Patients.

Authors:  Huei-Tzu Chien; Chi-Chin Yeh; Chi-Kuang Young; Tzu-Ping Chen; Chun-Ta Liao; Hung-Ming Wang; Kai-Lun Cho; Shiang-Fu Huang
Journal:  J Pers Med       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.